Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

stragen nordic a/s - desogestrel + etinilestradiol - comprimido - 0.15 mg + 0.02 mg - desogestrel 0.15 mg ; etinilestradiol 0.02 mg - desogestrel and ethinylestradiol - genérico - duração do tratamento: longa duração

Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

stragen nordic a/s - desogestrel + etinilestradiol - comprimido - 0.15 mg + 0.02 mg - desogestrel 0.15 mg ; etinilestradiol 0.02 mg - desogestrel and ethinylestradiol - genérico - duração do tratamento: longa duração

USA - engelsk - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - desogestrel and ethinyl estradiol tablets usp, 0.15 mg/0.03 mg are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with desogestrel and ethinyl estradiol tablets, 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. table 1:  percentage of women experiencing an unintended pregnancy during the first year of typical use an

Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

stragen nordic a/s - desogestrel + etinilestradiol - comprimido - 0.15 mg + 0.02 mg - desogestrel 0.15 mg ; etinilestradiol 0.02 mg - desogestrel and ethinylestradiol - genérico - duração do tratamento: longa duração

Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

stragen nordic a/s - desogestrel + etinilestradiol - comprimido - 0.15 mg + 0.03 mg - desogestrel 0.15 mg ; etinilestradiol 0.03 mg - desogestrel and ethinylestradiol - genérico - duração do tratamento: longa duração

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

teva nederland b.v. swensweg 5 2031 ga haarlem - desogestrel 150 µg/stuk ; ethinylestradiol 20 µg/stuk - tablet - aardappelzetmeel ; lactose 0-water ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; tocoferol, dl-alfa (e 307), aardappelzetmeel ; lactose 0-water ; povidon (e 1201) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; tocoferol, dl-alfa (e 307), - desogestrel and ethinylestradiol

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

teva nederland b.v. swensweg 5 2031 ga haarlem - desogestrel 150 µg/stuk ; ethinylestradiol 30 µg/stuk - tablet - aardappelzetmeel ; lactose 0-water ; povidon (e 1201) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; tocoferol, dl-alfa (e 307), - desogestrel and ethinylestradiol

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

teva nederland b.v. swensweg 5 2031 ga haarlem - desogestrel 150 µg/stuk ; ethinylestradiol 20 µg/stuk - tablet - aardappelzetmeel ; lactose 0-water ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; tocoferol, dl-alfa (e 307), - desogestrel and ethinylestradiol

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

teva nederland b.v. swensweg 5 2031 ga haarlem - desogestrel 150 µg/stuk ; ethinylestradiol 30 µg/stuk - tablet - aardappelzetmeel ; lactose 0-water ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; tocoferol, dl-alfa (e 307), - desogestrel and ethinylestradiol

Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

mylan, lda. - desogestrel - comprimido - 0.075 mg - desogestrel 0.075 mg - desogestrel - genérico - duração do tratamento: longa duração